Giulia Corrao

European Institute of Oncology

Papers

1

Total Citations

9

H-Index

1

About

Giulia Corrao is a prominent clinician-researcher whose work centers on the surgical and radiotherapeutic management of head and neck cancers, with a particular focus on HPV-positive oropharyngeal squamous cell carcinoma. Her major contributions lie in providing real-world evidence comparing modern treatment paradigms, most notably through her landmark 2022 study comparing upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) for locally advanced HPV-positive oropharyngeal cancer. This work, which has garnered 9 citations, offers critical insights into oncologic and functional outcomes from a tertiary comprehensive cancer centre, helping to guide clinical decision-making in a rapidly evolving field. By analyzing stage III and IV patients, Corrao addresses the pressing need for data that reflects actual clinical practice rather than controlled trial settings. Her research is instrumental in balancing the goals of tumor control with quality of life preservation, a key challenge in head and neck oncology. Through her rigorous comparative analyses, Corrao has established herself as a key voice in the debate over optimal treatment sequencing for this patient population, making her work essential reading for surgeons, radiation oncologists, and trainees navigating the complexities of modern multidisciplinary care.

Research Focus

Key Achievements

1
H-Index
1
Papers
9
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Upfront transoral robotic surgery (TORS) versus intensity-modulated radiation therapy (IMRT) in HPV-positive oropharyngeal cancer: real-world data from a tertiary comprehensive cancer centre
9 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: European Institute of Oncology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago